Treatment with 3-DZNep, a EZH2 inhibitor can induce selective apoptosis of alloantigen-activated T cells and arrest persistent graft-versus-host disease (GVHD) in mice after allogeneic bone marrow transplantation (He et al., 2012). The gene discussed is EZH2; the disease is graft versus host disease.